Marvell price target raised by Bank of America on $80 billion sales outlook

BofA raised Marvell's price target to $400 from $365 and maintained its Buy rating after the analyst day. Marvell targets $70 billion–$90 billion in 2030 sales, with an approximately $80 billion midpoint implying CAGR above 60% from 2026, versus consensus of $43 billion.

Analysis

The key market question is whether the 2030 ambition represents secured, production-ready programs or a broad opportunity set. A target far above current consensus can support a longer-duration growth premium, but it also raises the bar for design-win conversion, customer ramp timing and supply-chain capacity. Until those elements are quantified, treat the ambition as an option on future growth—not as near-term earnings evidence.

The upside case is that hyperscalers continue shifting workloads toward custom accelerators, lifting demand for both custom silicon and the networking that connects AI infrastructure. That could benefit Marvell while increasing competitive pressure on merchant platforms and rival custom-chip providers, including Broadcom and Nvidia. The counter-risk is that a small number of large buyers retain bargaining power, delay programs or shift designs in-house; a large headline target could then magnify multiple compression if ramps slip.

Near term, analyst-day enthusiasm may drive estimate revisions and momentum, but the 1–3 month test is independent evidence: customer/program disclosures, revenue visibility and updated financial guidance. Over 6–18 months, monitor whether custom-chip and data-center networking growth converts into reported results. The contrarian point: investors may be anchoring to the 2030 endpoint while underweighting the execution path—and the possibility that a long-dated target already attracts a valuation premium. No valuation or program-level data here supports a price target.

Key Decisions for Investors

• Do not chase the analyst-day reaction on the target alone. Before adding exposure, verify what businesses and customer programs underpin the 2030 range, the expected ramp schedule, and whether management ties it to measurable intermediate milestones.
• For investors seeking upside, consider a staged MRVL entry after confirmation in subsequent results or guidance that data-center/custom-silicon growth is translating into revenue. Keep position sizing sensitive to customer concentration and long-duration valuation risk.
• Watch for a relative-value opportunity between Marvell and established custom-silicon competitors such as Broadcom, but do not initiate a pair without comparing program wins, growth expectations and valuation; those data are absent here.
• Falsify the bullish thesis if management reduces or fails to substantiate intermediate growth milestones, customer ramps slip, or reported data-center/custom-silicon performance diverges from the opportunity narrative. Reassess promptly if guidance or program disclosures weaken.